Cargando…

Recent Advances in Nanotherapeutics for Multiple Myeloma

SIMPLE SUMMARY: Nanotherapeutics are useful tools to improve the deliverability of drugs, especially anti-cancer drugs that need to target specific cells. Several approaches have been studied for multiple myeloma, considering that immune cells are not easy to target with the available drugs. These p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iannazzo, Daniela, Ettari, Roberta, Giofrè, Salvatore, Eid, Ali H., Bitto, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693822/ https://www.ncbi.nlm.nih.gov/pubmed/33120945 http://dx.doi.org/10.3390/cancers12113144

Ejemplares similares

Theranostic Applications of 2D Graphene-Based Materials for Solid Tumors Treatment
por: Iannazzo, Daniela, et al.
Publicado: (2023)

Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2021)

Recent advances in nanotherapeutics for the treatment of burn wounds
por: Huang, Rong, et al.
Publicado: (2021)

Recent Advances in Nanotherapeutics for Neurological Disorders
por: Vashist, Arti, et al.
Publicado: (2023)

Recent advances in nanotherapeutics for the treatment and prevention of acute kidney injury
por: Yu, Hui, et al.
Publicado: (2021)

Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma MM.1R cells
por: Ettari, Roberta, et al.
Publicado: (2019)

Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease
por: Si, Xiao-Ying, et al.
Publicado: (2016)

Monoclonal Antibodies: The Greatest Resource to Treat Multiple Myeloma
por: De Luca, Fabiola, et al.
Publicado: (2023)

Recent advances in understanding multiple myeloma
por: Dhakal, Binod, et al.
Publicado: (2016)

Advances in personalized nanotherapeutics
por: Kaushik, Ajeet, et al.
Publicado: (2017)

Recent Advances in the Management of Smoldering Multiple Myeloma
por: Madhira, Bhaskara Reddy, et al.
Publicado: (2020)

Recent Advances in the Treatment of Patients with Multiple Myeloma
por: Legarda, Mario A., et al.
Publicado: (2020)

ZnO nanotherapeutics for the treatment of burn wounds: recent advances: Correspondence
por: Hemmami, Hadia, et al.
Publicado: (2023)

Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor
por: Wei, Xiao, et al.
Publicado: (2022)

Recent advances in multiple myeloma: a Korean perspective
por: Hong, Junshik, et al.
Publicado: (2016)

Extracellular Vesicles as Nanotherapeutics for Parkinson’s Disease
por: Leggio, Loredana, et al.
Publicado: (2020)

Smart Nanotherapeutics and Lung Cancer
por: Doroudian, Mohammad, et al.
Publicado: (2021)

Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells
por: Mannino, Federica, et al.
Publicado: (2021)

Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
por: Hattab, Dima, et al.
Publicado: (2021)

Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma
por: Abramson, Hanley N.
Publicado: (2023)

Nanotherapeutics in Neuropathologies: Obstacles, Challenges and Recent Advancements in CNS Targeted Drug Delivery Systems
por: Patel, Vimal, et al.
Publicado: (2021)

Recent advances in the treatment of multiple myeloma: a brief review
por: Bobin, Arthur, et al.
Publicado: (2022)

How Advanced are Cancer Immuno-Nanotherapeutics? A Comprehensive Review of the Literature
por: Yadav, Dhananjay, et al.
Publicado: (2023)

Graphene Quantum Dots by Eco-Friendly Green Synthesis for Electrochemical Sensing: Recent Advances and Future Perspectives
por: Bressi, Viviana, et al.
Publicado: (2021)

CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma
por: Martino, Massimo, et al.
Publicado: (2021)

Recent Advances on the Pathobiology and Treatment of Multiple Myeloma
por: Amodio, Nicola
Publicado: (2021)

Recent Advances in the Understanding and Treatment of Multiple Myeloma
por: Cook, Richard, et al.
Publicado: (2008)

Nanotherapeutics for treating coronavirus diseases
por: Gunathilake, Thennakoon M. Sampath U., et al.
Publicado: (2021)

Immune Repertoire and Advancements in Nanotherapeutics for the Impediment of Severe Steroid Resistant Asthma (SSR)
por: Beeraka, Narasimha M, et al.
Publicado: (2022)

Correction: Mannino et al. Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells. Cancers 2021, 13, 5741
por: Mannino, Federica, et al.
Publicado: (2023)

Blunting Neuroinflammation by Targeting the Immunoproteasome with Novel Amide Derivatives
por: Imbesi, Chiara, et al.
Publicado: (2023)

Cell Membrane-Cloaked Nanotherapeutics for Targeted Drug Delivery
por: Lee, Na-Hyun, et al.
Publicado: (2022)

Recent Advances in the Treatment Of Newly Diagnosed Multiple Myeloma
por: Libby, Edward, et al.
Publicado: (2020)

Potential nanotherapeutic strategies for perioperative stroke
por: An, Jingyi, et al.
Publicado: (2022)

Utilizing the folate receptor for active targeting of cancer nanotherapeutics
por: Zwicke, Grant L., et al.
Publicado: (2012)

Targeted nanotherapeutics in cancer
por: Shiekh, Farooq A
Publicado: (2014)

Polymeric nanomaterials for nanotherapeutics
por: Vasile, Cornelia
Publicado: (2018)

Antitumor Features of Vegetal Protein-Based Nanotherapeutics
por: Voci, Silvia, et al.
Publicado: (2020)

Imaging Nanotherapeutics in Inflamed Vasculature by Intravital Microscopy
por: Wang, Zhenjia
Publicado: (2016)

Vascular targeted nanotherapeutic approach for obesity treatment
por: Sibuyi, Nicole Remaliah Samantha, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l2k4mv7lnlbqgavm19qkip6ovu